+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticonvulsants"

From
Krabbe Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Krabbe Disease Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 194 Pages
  • Global
From
Acute Repetitive Seizures - Global Strategic Business Report - Product Thumbnail Image

Acute Repetitive Seizures - Global Strategic Business Report

  • Report
  • October 2026
  • 180 Pages
  • Global
From
Cerebral Infarction Treatment - Global Strategic Business Report - Product Thumbnail Image

Cerebral Infarction Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 372 Pages
  • Global
From
Paresthesia Treatment - Global Strategic Business Report - Product Thumbnail Image

Paresthesia Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 381 Pages
  • Global
From
Migraine Drugs - Global Strategic Business Report - Product Thumbnail Image

Migraine Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 500 Pages
  • Global
From
Leigh Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Leigh Syndrome Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 477 Pages
  • Global
From
Prion Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Prion Disease Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 268 Pages
  • Global
From
From
Dystonia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dystonia Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 369 Pages
  • Global
From
Neuralgia Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 276 Pages
  • Global
From
From
From
Infantile Spasm Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Infantile Spasm Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 377 Pages
  • Global
From
Intracranial Hematoma Drug Market Report 2026 - Product Thumbnail Image

Intracranial Hematoma Drug Market Report 2026

  • Report
  • July 2026
  • 250 Pages
  • Global
From
From
Rare Neurological Disease Treatment Market Report 2026 - Product Thumbnail Image

Rare Neurological Disease Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Neuropathic Pain Market Report 2026 - Product Thumbnail Image

Neuropathic Pain Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Neuralgia Treatment Market Report 2026 - Product Thumbnail Image

Neuralgia Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Central Nervous System Therapeutics Market Report 2026 - Product Thumbnail Image

Central Nervous System Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator

Anticonvulsants are a class of drugs used to treat seizures and other neurological disorders. They work by reducing the abnormal electrical activity in the brain that causes seizures. Anticonvulsants are used to treat a variety of conditions, including epilepsy, bipolar disorder, and neuropathic pain. They are also used to prevent seizures in people with certain types of brain injuries. Anticonvulsants are part of the larger class of Central Nervous System (CNS) drugs, which also includes antidepressants, antipsychotics, and anxiolytics. The anticonvulsant market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more